AKINDELE KOLADE: Open Payments
NPI 1922051846 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 16 payments from 5 companies in 2025. Trend: 2023 $72 · 2024 $288 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $160 |
| Sage Therapeutics, LLC | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
Products named: CAPLYTA, ZURZUVAE, SPRAVATO, REXULTI, ABILIFY ASIMTUFII, Qelbree.
Industry payments across NV — which companies pay providers there.
